Prospective evaluation of the Kaiser Permanente prostate cancer risk calculator in biopsy-naïve men with mild PSA elevations

被引:0
|
作者
Presti, Joseph
Horton, Brandon
Alexeeff, Stacey
Prausnitz, Stephanie
Avins, Andrew
机构
[1] Kaiser Permanente, San Francisco, CA USA
[2] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA
关键词
3282-206-3782-4974; 2;
D O I
10.1200/JCO.2024.42.4_suppl.290
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:290 / 290
页数:1
相关论文
共 50 条
  • [41] A PROSPECTIVE EVALUATION ON THE EFFECT OF INTER-OBSERVER VARIABILITY OF DRE ON THE PERFORMANCE OF THE DRE BASED ROTTERDAM PROSTATE CANCER RISK CALCULATOR
    Pereira-Azevedo, Nuno
    Braga, Isaac
    Verbeek, Jan F. M.
    Osorio, Luis
    Cavadas, Vitor
    Fraga, Avelino
    Carrasquinho, Eduardo
    de Oliveira, Eduardo Cardoso
    Nieboer, Daan
    Roobol, Monique J.
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1026 - E1027
  • [42] Prospective evaluation of the utility of %P2psa and the Prostate Health Index (PHI), in predicting prostate cancer in initial prostate biopsies of Singaporean men, with total PSA between 4.0 and 10 ng/ml
    Goh, Y. S. B.
    Tan, G. L. L.
    Tan, Y. K.
    Tai, B. C.
    Tan, K. M. L.
    Hawkins, R. C. W.
    Hong, F.
    Chiong, E.
    BJU INTERNATIONAL, 2015, 115 : 3 - 3
  • [43] Identifying Candidates for Active Surveillance: An Evaluation of the Repeat Biopsy Strategy for Men with Favorable Risk Prostate Cancer REPLY
    不详
    JOURNAL OF UROLOGY, 2012, 188 (03): : 768 - 768
  • [44] BODY MASS INDEX AND PROSTATE SIZE IMPROVE PERFORMANCE OF A PROSTATE CANCER RISK CALCULATOR AT HIGH LEVELS OF SENSITIVITY FOR PREDICTING PROSTATE CANCER AT INITIAL PROSTATE BIOPSY: RESULTS FROM A PROSPECTIVE, MULTI-CENTER COHORT
    Salami, Simpa
    Wei, John
    Regan, Meredith
    Scherr, Douglas
    Siddiqui, Javed
    Kearney, Michael
    Eyre, Robert
    Dewolf, William
    Rubin, Mark
    Sanda, Martin
    JOURNAL OF UROLOGY, 2010, 183 (04): : E818 - E819
  • [45] Low testosterone at first PSA failure and assessment of the risk of death in men with unfavorable-risk prostate cancer treated on prospective clinical trials.
    Atkins, Katelyn Mae
    Chen, Ming-Hui
    Wu, Jing
    Renshaw, Andrew A.
    Loffredo, Marian
    Kantoff, Philip W.
    Small, Eric Jay
    D'Amico, Anthony Victor
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [46] Potential effect of anti-inflammatory drug use on PSA kinetics and subsequent prostate cancer diagnosis: Risk stratification in black and white men with benign prostate biopsy
    Kryvenko, Oleksandr N.
    Wang, Yun
    Sadasivan, Sudha
    Gupta, Nilesh S.
    Rogers, Craig
    Bobbitt, Kevin
    Chitale, Dhananjay A.
    Rundle, Andrew
    Tang, Deliang
    Rybicki, Benjamin A.
    PROSTATE, 2019, 79 (10): : 1090 - 1098
  • [47] Is multiparametric MRI always needed in biopsy-naïve patients with abnormal digital rectal examination? A single-institutional experience combining clinical and micro-ultrasonography-based factors to optimize prostate cancer detection
    Avolio, Pier Paolo
    Lazzeri, Massimo
    Maffei, Davide
    Fasulo, Vittorio
    Frego, Nicola
    Saitta, Cesare
    de Carne, Fabio
    Paciotti, Marco
    Saita, Alberto
    Hurle, Rodolfo
    Guazzoni, Giorgio
    Casale, Paolo
    Buffi, Nicolo Maria
    Lughezzani, Giovanni
    WORLD JOURNAL OF UROLOGY, 2024, 42 (01)
  • [48] Re: Short Term Outcomes of Prostate Biopsy in Men Tested for Cancer by Prostate Specific Antigen: Prospective Evaluation Within ProtecT Study Editorial Comment
    Penson, David F.
    JOURNAL OF UROLOGY, 2012, 188 (03): : 811 - 813
  • [49] Identifying Candidates for Active Surveillance: An Evaluation of the Repeat Biopsy Strategy for Men with Favorable Risk Prostate Cancer EDITORIAL COMMENT
    Haas, Gabriel P.
    Delongchamps, Nicolas Barry
    JOURNAL OF UROLOGY, 2012, 188 (03): : 767 - 768
  • [50] Evaluation of prostate-specific antigen density in the diagnosis of prostate cancer combined with magnetic resonance imaging before biopsy in men aged 70 years and older with elevated PSA
    Yanai, Yoshinori
    Kosaka, Takeo
    Hong, Hiroshi
    Matsumoto, Kazuhiro
    Shinojima, Toshiaki
    Kikuchi, Eiji
    Miyajima, Akira
    Mizun, Ryuichi
    Mikami, Shuji
    Jinzaki, Masahiro
    Oya, Mototsugu
    MOLECULAR AND CLINICAL ONCOLOGY, 2018, 9 (06) : 656 - 660